Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Firms / B••• M••••••••• L•••

B••• M••••••••• L•••

Institutional venture firm · probableShanghaib•••.comSEC exempt reporting adviser

BioVeda China Fund (BVCF) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, and Bejing

venture manager, reported GAV $463M across 6 vehicles

Importance
28
moderate
Active deployment
0
low
Emerging
0
low
Completeness
56
elevated
Freshness
98
high
Research priority
6
low
Identity and regulatory footprint
Headquarters
Shanghai, Chinaadviserinfo.sec.gov
Office address
763 MENGZI ROAD, SUITE 2606, Shanghai, 200023adviserinfo.sec.gov
Business phone
(86 21) 6315 1313adviserinfo.sec.gov
SEC adviser type
exempt reporting adviseradviserinfo.sec.gov
SEC exemption claimed
private fund adviseradviserinfo.sec.gov
Latest Form ADV
Mar 18, 2024
Private funds reported
6 (3 venture capital funds)adviserinfo.sec.gov
Private fund gross assets
$463Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
business email
info@bvcf.combvcf.compublished by the subject
business phone
(86 21) 6315 1313adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
no observed deals yet
Stated (the firm’s website)
Sectors
biotech
Stages
not stated or not yet read
Geography
global
Check size
not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors: no observed deals yet
lead rate n/afollow-on rate n/anew logos, 12 months 0
Funds and vehicles
6 reported, 1 no longer reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
B••• C•••••••• a• L•••SPV or co-invest vehicle2021 adv first reportedMature$6.9M
Mar 18, 2024
1unknownunknown
B••• R••••••••• F•••• L•••Fund · ADV: Private Equity Fund2019 adv first reportedMature$193M
Mar 18, 2024
19$0Nov 19, 2018
B••• I•• L•••Fund2017 form d first saleHarvest$136M
Mar 18, 2024
17$41.0MDec 10, 2018
B••• I••• L•••Fund · ADV: Private Equity Fund2012 form d first saleHarvest$83.6M
Mar 18, 2024
29$80.0M
of $200M
Aug 23, 2012
B•••••• C•••• F••• I•• L•FundunknownUnknown$36.3M
Mar 18, 2024
15unknownunknown
B••• I••••• L•••Feeder or parallel · ADV: Private Equity FundunknownUnknown$6.9M
Mar 18, 2024
4unknownunknown
B•••••• C••••• L•FundunknownWound down$83,645
Mar 2, 2017
11unknownunknown
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
3 current, 0 departed
Investments on record
0 edges, 0 companies, 0 partner-attributed
No investment on record yet. Edges arrive from the firm’s portfolio page, financing announcements, and Form D board seats.
Co-investors
0 relationships from shared deals, counted for the whole firm
No co-investor relationship yet: these are derived only from rounds and portfolio listings the graph has seen both investors on.
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
9 dated events
  1. Mar 31, 2021
    B••• C•••••••• a• L••• first reported on Form ADV by B••• M••••••••• L••• (Venture Capital Fund), GAV $10,000,000
  2. Mar 28, 2019
    B••• R••••••••• F•••• L••• first reported on Form ADV by B••• M••••••••• L••• (Private Equity Fund), GAV $225,399,439
  3. Mar 20, 2018
    B••• I•• L••• first reported on Form ADV by B••• M••••••••• L••• (Venture Capital Fund), GAV $127,530,000
  4. Mar 20, 2018
    B•••••• C••••• L• no longer reported on Form ADV by B••• M••••••••• L•••
  5. Aug 27, 2014
    B••• M••••••••• L••• first filed Form ADV (ERA, venture capital fund adviser exemption)
  6. Aug 27, 2014
    B••• I••••• L••• first reported on Form ADV by B••• M••••••••• L••• (Venture Capital Fund), GAV $4,669,123
  7. Aug 27, 2014
    B•••••• C•••• F••• I•• L• first reported on Form ADV by B••• M••••••••• L••• (Venture Capital Fund), GAV $73,961,854
  8. Aug 27, 2014
    B•••••• C••••• L• first reported on Form ADV by B••• M••••••••• L••• (Venture Capital Fund), GAV $33,191,685
  9. Aug 27, 2014
    B••• I••• L••• first reported on Form ADV by B••• M••••••••• L••• (Venture Capital Fund), GAV $46,329,977
Classification history
  1. Sep 12, 2026
    Institutional venture firm (probable, 80%, cls-1)
    venture manager, reported GAV $463M across 6 vehicles
Evidence
38 observations from 2 sources
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
SEC exemption claimedprivate_fund_adviserMar 18, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC adviser typeexempt_reporting_adviserMar 18, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2014-08-27Mar 18, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Adv history loadedadv-hist-1Sep 12, 2026FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2024-03-18Mar 18, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Venture share of reported funds1Mar 18, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone(86 21) 6315 1313Mar 18, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Contact page urlhttps://b•••.com/
contact page linked from the home page
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
DescriptionBioVeda C•••• Fund (BVCF) is a leading biomedical venture capital firm headquartered in C••••, with offices in Shanghai, and Bejing
meta description
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
DescriptionBioVeda C•••• Fund (BVCF) is a leading biomedical venture capital firm headquartered in C••••, with offices in Shanghai, and Bejing
meta description
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
HeadquartersShanghai, C••••Mar 18, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office address763 MENGZI ROAD, SUITE 2606, Shanghai, 200023Mar 18, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Legal formOther (specify)Mar 18, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Portfolio pagehttps://b•••.com/
0 entries read
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Portfolio pagehttps://b•••.com/
0 entries read
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Private funds reported6Mar 18, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private fund gross assets (reported)$463MMar 18, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Stated geographyglobal
geography words on the home page
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated geographyglobal
geography words on the home page
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorsbiotech
sector words on the home page
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorsbiotech
sector words on the home page
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://b•••.com/
0 name/title pairs read
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://b•••.com/
0 name/title pairs read
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Venture funds reported3Mar 18, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
WebsiteHTTP://w••.b•••.com/Mar 18, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Site titleBioVeda C•••• Fund (BVCF)
title tag
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Site titleBioVeda C•••• Fund (BVCF)
title tag
Sep 13, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)